Skip to main content
HCPCS J9100 · Level II · Part B drug

J9100: cytarabine, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J9100

Billing unit
100 MG
Cytarabine hcl 100 mg inj
ASP payment limit
$0.853
October 2026; +0.0% vs July 2026
Practitioner MUE
120
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J9100 is the Level II code for Injection, cytarabine, 100 mg, billed per 100 MG. The Medicare Part B ASP payment limit for October 2026 is $0.853 per billing unit, up 0.0% from July 2026. The practitioner MUE allows up to 120 units per date of service (MAI 3), so a full 120-unit day is $102.36 at the current limit. Under OPPS it carries status indicator N. J9100 is billed in units of 100 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 9 NDCs to it, sold as Cytarabine by Sagent Pharmaceuticals, Pfizer Inc, FreseniUS Kabi USA, LLC. No current Billing and Coding Article lists J9100, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J9100 at $0.853 per 100 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.853 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J9100
QuarterPayment limitPerCoinsurance
October 2026$0.853100 MG20%
July 2026$0.853100 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 9 NDCs from 4 labelers to J9100. Report the NDC in the claim's drug segment and bill the number of J9100 units that equals the quantity administered divided by 100 MG; the last column gives units per full package.

NDCs that crosswalk to J9100
NDCDrug nameLabelerPackage sizeBilling units / package
25021-0223-20CytarabineSagent Pharmaceuticals20 × 120
25021-0229-05CytarabineSagent Pharmaceuticals5 × 55
61703-0155-01CytarabinePfizer Inc20 × 120
61703-0303-46CytarabinePfizer Inc50 × 110
61703-0304-36CytarabinePfizer Inc25 × 15
61703-0305-38CytarabinePfizer Inc5 × 55
61703-0319-22CytarabinePfizer Inc20 × 120
63323-0120-20CytarabineFreseniUS Kabi USA, LLC1 × 120
71288-0109-20CytarabineMeitheal Pharmaceuticals Inc.20 × 120

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J9100. For practitioners the limit is 120 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J9100 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services1203 Date of Service Edit: ClinicalClinical: Society Comment
Facility outpatient hospital1203 Date of Service Edit: ClinicalClinical: Society Comment
DME supplier603 Date of Service Edit: ClinicalClinical: Data

MUE for J9100 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J9100 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J9100 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J9100 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J9100 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Local coverage policies that list J9100

1 active Local Coverage Determination lists J9100 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J9100 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J9100 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J9100 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J9100

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J9100

What does HCPCS code J9100 describe?

J9100 is defined by CMS as "Injection, cytarabine, 100 mg". Each billing unit represents 100 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J9100 a CPT code?

No. J9100 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as cytarabine; CPT codes are five-character codes maintained by the AMA. On a Part B claim J9100 reports the drug itself in 100 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J9100 in October 2026?

The ASP-based payment limit is $0.853 per 100 MG, with 20% beneficiary coinsurance. The July 2026 limit was $0.853. Commercial payers use their own fee schedules.

How many units of J9100 can be billed per day?

The practitioner Medically Unlikely Edit is 120 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Society Comment" as the rationale.

Which NDCs map to J9100?

The October 2026 ASP crosswalk lists 9 NDCs from 4 labelers: Cytarabine (Sagent Pharmaceuticals); Cytarabine (Pfizer Inc); Cytarabine (FreseniUS Kabi USA, LLC); Cytarabine (Meitheal Pharmaceuticals Inc.). For example NDC 25021-0223-20 (package size 20) equals 20 billing units of J9100.

Does J9100 have NCCI bundling edits?

No active practitioner PTP pairs list J9100 as a column-1 or column-2 code in the v323r0 release.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.